Stay updated with breaking news from Neil Kumar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CEO Neil Kumar sold 120,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 5th. The shares were sold at an average price of $15.46, for a total value of $1,855,200.00. Following the completion of the transaction, the chief executive officer now directly owns […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CFO Brian C. Stephenson sold 55,500 shares of the company’s stock in a transaction that occurred on Wednesday, April 5th. The stock was sold at an average price of $15.45, for a total transaction of $857,475.00. Following the completion of the transaction, the chief financial officer now owns […]
/PRNewswire/ -- Applied BioMath (www.appliedbiomath.com), the industry-leader in providing model-informed drug discovery and development (MID3) support to help...
Takeover interest is spurring these two biotech stocks higher.
BridgeBio's latest results could set the bar in efficacy for treating the most common cause of short stature.